Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status
We investigated the effect of the mammalian target of rapamycin (mTOR) inhibitor everolimus on tuberous sclerosis complex- (TSC-) associated autistic symptoms and focal seizures with impaired awareness in a female child with TSC. We further evaluated the relationship between improved autistic sympto...
Saved in:
Main Authors: | Kunio Yui, George Imataka, Hitomi Sasaki, Yohei Kawasaki, Tohru Okanshi, Ryoichi Shiroki, Shigemi Yoshihara |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2019/2070619 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Development of Methods of BLOTCHIP<sup>®</sup>-MS for Peptidome: Small Samples in Tuberous Sclerosis
by: Kunio Yui, et al.
Published: (2025-01-01) -
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study
by: Ruopeng Su, et al.
Published: (2024-09-01) -
Resting state EEG in young children with Tuberous Sclerosis Complex: associations with medications and seizures
by: Caitlin C. Clements, et al.
Published: (2025-01-01) -
Tuberous sclerosis. Case presentation.
by: Graciela Caridad Cabrera Acea, et al.
Published: (2009-03-01) -
Reversed Halo Sign in Tuberous Sclerosis Complex
by: Kazuhiro Suzuki, et al.
Published: (2013-01-01)